tiprankstipranks
Anavex Life Sciences (CH:12X1)
NASDAQ:12X1
Switzerland Market
12X1
Anavex Life Sciences
RESEARCH TOOLSreports

Anavex Life Sciences (12X1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

12X1 Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Anavex
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

12X1 Stock 12 Month Forecast

Average Price Target

$16.14
Based on 2 Wall Street analysts offering 12 month price targets for Anavex Life Sciences in the last 3 months. The average price target is $16.14 with a high forecast of $16.14 and a low forecast of $16.14. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$16.14Average Price Target$16.14Lowest Price Target$16.14
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Rodman & Renshaw Analyst forecast on CH:12X1
Seema Sheoran
Rodman & Renshaw
Rodman & Renshaw
CHF16.14
Buy
―
Initiated
05/04/26
Anavex initiated with a Buy at Rodman & RenshawAnavex initiated with a Buy at Rodman & Renshaw
H.C. Wainwright Analyst forecast on CH:12X1
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
CHF16.14
Buy
―
Reiterated
03/31/26
Reaffirming Buy on Anavex: Long-Term Value in Blarcamesine Outweighs Near-Term Regulatory Setbacks
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Rodman & Renshaw Analyst forecast on CH:12X1
Seema Sheoran
Rodman & Renshaw
Rodman & Renshaw
CHF16.14
Buy
―
Initiated
05/04/26
Anavex initiated with a Buy at Rodman & RenshawAnavex initiated with a Buy at Rodman & Renshaw
H.C. Wainwright Analyst forecast on CH:12X1
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
CHF16.14
Buy
―
Reiterated
03/31/26
Reaffirming Buy on Anavex: Long-Term Value in Blarcamesine Outweighs Near-Term Regulatory Setbacks
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Anavex Life Sciences

3 Months
Ram SelvarajuH.C. Wainwright
Success Rate
6/16 ratings generated profit
38%
Average Return
-11.47%
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of -11.47% per trade.
1 Year
Ram SelvarajuH.C. Wainwright
Success Rate
1/16 ratings generated profit
6%
Average Return
-49.43%
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 6.25% of your transactions generating a profit, with an average return of -49.43% per trade.
2 Years
Ram SelvarajuH.C. Wainwright
Success Rate
0/16 ratings generated profit
0%
Average Return
-57.69%
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -57.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

12X1 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
3
3
2
2
1
Buy
0
0
0
0
0
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
2
In the current month, 12X1 has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 12X1 average Analyst price target in the past 3 months is 16.14.
Each month's total comprises the sum of three months' worth of ratings.

12X1 Financial Forecast

12X1 Earnings Forecast

Next quarter’s earnings estimate for 12X1 is -$0.06 with a range of -$0.06 to -$0.06. The previous quarter’s EPS was -$0.05. 12X1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 12X1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 12X1 is -$0.06 with a range of -$0.06 to -$0.06. The previous quarter’s EPS was -$0.05. 12X1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 12X1 has Performed in-line its overall industry.
No data currently available

12X1 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

12X1 Stock Forecast FAQ

What is CH:12X1’s average 12-month price target, according to analysts?
Based on analyst ratings, Anavex Life Sciences’s 12-month average price target is 16.14.
    What is CH:12X1’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:12X1, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Anavex Life Sciences a Buy, Sell or Hold?
        Anavex Life Sciences has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Anavex Life Sciences’s share price target?
          The average share price target for Anavex Life Sciences is 16.14. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $16.14 ,and the lowest forecast is $16.14. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Anavex Life Sciences?
            Anavex Life Sciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
              How can I buy shares of Anavex Life Sciences?
              To buy shares of CH:12X1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.